PD-1/PD-L1 blockade can enhance HIV-1 gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines

Molecular Therapy

Volumn 20, Issue 9, 2012, Pages 1800-1809

  Dai, Bingbing ^a   Xiao, Liang ^a   Bryson, Paul D ^a   Fang, Jinxu ^a   Wang, Pin ^a,b  

^a University of Southern California   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; EPITOPE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; LENTIVIRUS VECTOR; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 1 ANTIBODY; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOSTIMULATION; INFECTION CONTROL; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; SINGLE DRUG DOSE; VACCINATION; VACCINIA; VACCINIA VIRUS; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; VACCINIA VIRUS;

EID: 84867079698     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.98     Document Type: Article

References (40)

1. Trautmann, L, Janbazian, L, Chomont, N, Said, EA, Gimmig, S, Bessette, B et al. (2006). Upregulation of PD-1 expression on HIV-specifc CD8 T cells leads to reversible immune dysfunction. Nat Med 12: 1198-1202. (Pubitemid 44527357)
2. Petrovas, C, Price, DA, Mattapallil, J, Ambrozak, DR, Geldmacher, C, Cecchinato, V et al. (2007). SIV-specifc CD8 T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110: 928-936. (Pubitemid 47267431)
3. Zhang, JY, Zhang, Z, Wang, X, Fu, JL, Yao, J, Jiao, Y et al. (2007). PD-1 up-regulation is correlated with HIV-specifc memory CD8 T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 109: 4671-4678. (Pubitemid 46827757)
4. Larrubia, JR, Benito-Martínez, S, Miquel, J, Calvino, M, Sanz-de-Villalobos, E, González-Praetorius, A et al. (2011). Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(+) HCV-specifc CD8(-) cells targeting the virus in chronic hepatitis C virus infection. Cell Immunol 269: 104-114.
5. Khoury, SJ and Sayegh, MH (2004). The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20: 529-538. (Pubitemid 38638123)
6. Ha, SJ, West, EE, Araki, K, Smith, KA and Ahmed, R (2008). Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunol Rev 223: 317-333. (Pubitemid 351986183)
7. Chen, L (2004). Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4: 336-347. (Pubitemid 38649276)
8. Shin, T, Yoshimura, K, Shin, T, Crafton, EB, Tsuchiya, H, Housseau, F et al. (2005). In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med 201: 1531-1541. (Pubitemid 40720999)
9. D'Souza, M, Fontenot, AP, Mack, DG, Lozupone, C, Dillon, S, Meditz, A et al. (2007). Programmed death 1 expression on HIV-specifc CD4 T cells is driven by viral replication and associated with T cell dysfunction. J Immunol 179: 1979-1987.
10. Day, CL, Kaufmann, DE, Kiepiela, P, Brown, JA, Moodley, ES, Reddy, S et al. (2006). PD-1 expression on HIV-specifc T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354. (Pubitemid 44435155)
11. Barber, DL, Wherry, EJ, Masopust, D, Zhu, B, Allison, JP, Sharpe, AH et al. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687. (Pubitemid 43237609)
12. Velu, V, Titanji, K, Zhu, B, Husain, S, Pladevega, A, Lai, L et al. (2009). Enhancing SIV-specifc immunity in vivo by PD-1 blockade. Nature 458: 206-210.
13. Ha, SJ, Mueller, SN, Wherry, EJ, Barber, DL, Aubert, RD, Sharpe, AH et al. (2008). Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 205: 543-555. (Pubitemid 351439302)
14. Porichis, F, Kwon, DS, Zupkosky, J, Tighe, D P, McMullen, A, Brockman, MA et al. (2011). Responsiveness of HIV-specifc CD4 T cells to PD-1 blockade. Blood 118: 965-974.
15. Macatangay, BJ and Rinaldo, CR (2009). PD-1 blockade: A promising immunotherapy for HIV? Cellscience 5: 61-65.
16. Trumpfheller, C, Finke, JS, López, CB, Moran, TM, Moltedo, B, Soares, H et al. (2006). Intensifed and protective CD4 T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J Exp Med 203: 607-617.
17. MacLeod, MK, McKee, AS, David, A, Wang, J, Mason, R, Kappler, JW et al. (2011). Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells. Proc Natl Acad Sci USA 108: 7914-7919.
18. de Arruda, LB, Chikhlikar, PR, August, JT and Marques, ET (2004). DNA vaccine encoding human immunodefciency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response. Immunology 112: 126-133.
19. Bonifaz, LC, Bonnyay, DP, Charalambous, A, Darguste, DI, Fujii, S, Soares, H et al. (2004). In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 199: 815-824. (Pubitemid 38375201)
20. Peggs, KS, Quezada, SA and Allison, JP (2008). Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol Rev 224: 141-165.
21. Yang, L, Yang, H, Rideout, K, Cho, T, Joo, KI, Ziegler, L et al. (2008). Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol 26: 326-334. (Pubitemid 351355129)
22. Zhang, L, Gajewski, TF and Kline, J (2009). PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Blood 114: 1545-1552.
23. Dai, B, Yang, L, Yang, H, Hu, B, Baltimore, D and Wang, P (2009). HIV-1 Gag-specifc immunity induced by a lentivector-based vaccine directed to dendritic cells. Proc Natl Acad Sci USA 106: 20382-20387.
24. Liu, J, Ewald, BA, Lynch, DM, Denholtz, M, Abbink, P, Lemckert, AA et al. (2008). Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. J Virol 82: 4844-4852. (Pubitemid 351657046)
25. Sun, Y, Schmitz, JE, Buzby, A P, Barker, BR, Rao, SS, Xu, L et al. (2006). Virus-specifc cellular immune correlates of survival in vaccinated monkeys after simian immunodefciency virus challenge. J Virol 80: 10950-10956. (Pubitemid 44706536)
26. Wu, L, Kong, WP and Nabel, GJ (2005). Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodefciency virus Env and Gag immunogens. J Virol 79: 8024-8031. (Pubitemid 40853506)
27. Kong, WP, Huang, Y, Yang, ZY, Chakrabarti, BK, Moodie, Z and Nabel, GJ (2003). Immunogenicity of multiple gene and clade human immunodefciency virus type 1 DNA vaccines. J Virol 77: 12764-12772. (Pubitemid 37430671)
28. Song, R, Liu, S and Leong, KW (2007). Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specifc immune response with DNA vaccines. Mol Ther 15: 1007-1015. (Pubitemid 46621660)
29. Harty, JT and Badovinac, VP (2008). Shaping and reshaping CD8 T-cell memory. Nat Rev Immunol 8: 107-119. (Pubitemid 351161304)
30. Colombetti, S, Lévy, F and Chapatte, L (2009). IL-7 adjuvant treatment enhances long-term tumor-antigen-specifc CD8 T-cell responses after immunization with recombinant lentivector. Blood 113: 6629-6637.
31. Sumida, SM, McKay, PF, Truitt, DM, Kishko, MG, Arthur, JC, Seaman, MS et al. (2004). Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J Clin Invest 114: 1334-1342. (Pubitemid 40385305)
32. Gilboa, E (2007). DC-based cancer vaccines. J Clin Invest 117: 1195-1203. (Pubitemid 46718404)
33. Petrovas, C, Casazza, JP, Brenchley, JM, Price, DA, Gostick, E, Adams, WC et al. (2006). PD-1 is a regulator of virus-specifc CD8 T cell survival in HIV infection. J Exp Med 203: 2281-2292. (Pubitemid 44498363)
34. He, Y, Zhang, J, Mi, Z, Robbins, P and Falo, LD Jr (2005). Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. J Immunol 174: 3808-3817. (Pubitemid 40354094)
35. Arruda, LB, Sim, D, Chikhlikar, PR, Maciel, M Jr, Akasaki, K, August, JT et al. (2006). Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular traffcking pathways and prime T and B cell responses to a diverse repertoire of epitopes. J Immunol 177: 2265-2275. (Pubitemid 44200986)
36. Fagarasan, S and Honjo, T (2000). T-Independent immune response: new aspects of B cell biology. Science 290: 89-92.
37. Yang, J, Riella, LV, Chock, S, Liu, T, Zhao, X, Yuan, X et al. (2011). The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. J Immunol 187: 1113-1119.
38. Najafan, N and Khoury, SJ (2003). T cell costimulatory pathways: blockade for autoimmunity. Expert Opin Biol Ther 3: 227-236. (Pubitemid 36458755)
39. Sharpe, AH, Wherry, EJ, Ahmed, R and Freeman, GJ (2007). The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8: 239-245. (Pubitemid 46745373)
40. Shin, EC and Rehermann, B (2006). Taking the brake off T cells in chronic viral infection. Nat Med 12: 276-277. (Pubitemid 43355069)